JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mense, M.
Right arrow Articles by Caplan, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mense, M.
Right arrow Articles by Caplan, M. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 3, 1749-1756, January 21, 2000


Residues of the Fourth Transmembrane Segments of the Na,K-ATPase and the Gastric H,K-ATPase Contribute to Cation Selectivity*

Martin MenseDagger §, Lisa A. DunbarDagger , Rhoda Blostein, and Michael J. CaplanDagger

From the Dagger  Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, Connecticut 06520-8026 and the  Departments of Medicine and Biochemistry, McGill University, Montreal, Quebec H3G 1A4, Canada

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We have generated protein chimeras to investigate the role of the fourth transmembrane segments (TM4) of the Na,K- and gastric H,K-ATPases in determining the distinct cation selectivities of these two pumps. Based on a helical wheel analysis, three residues of TM4 of the Na,K-ATPase were changed to their H,K-counterparts. A construct carrying three mutations in TM4 (L319F, N326Y, and T340S) and two control constructs were heterologously expressed in Xenopus laevis oocytes and in the pig kidney epithelial cell line LLC-PK1. Biochemical ATPase assays demonstrated a large sodium-independent ATPase activity at pH 6.0 for the pump carrying the TM4 substitutions, whereas the control constructs exhibited little or no activity in the absence of sodium. Furthermore, at pH 6.0 the K1/2(Na+) shifted to 1.5 mM for the TM4 construct compared with 9.4 and 5.9 mM for the controls. In contrast, at pH 7.5 all three constructs had characteristics similar to wild type Na,K-ATPase. Large increases in K1/2(K+) were observed for the TM4 construct compared with the control constructs both in two-electrode voltage clamp experiments in Xenopus oocytes and in ATPase assays. ATPase assays also revealed a 10-fold shift in vanadate sensitivity for the TM4 construct. Based on these findings, it appears that the three identified TM4 residues play an important role in determining both the specific cation selectivities and the E1/E2 conformational equilibria of the Na,K- and H,K-ATPase.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The P-type class of ion motive ATPases includes the Na,K-, H,K-, and Ca-ATPases. These molecules couple the energy liberated through ATP hydrolysis to the transmembrane translocation of cations. Much remains to be learned about the structural features of these pumps that determine their functional characteristics.

In this study we take advantage of the high mechanistic and functional homology relating the gastric H,K-ATPase and the Na,K-ATPase to investigate the molecular basis for their distinct cation selectivity properties. Both enzymes form functional heterodimers consisting of a larger alpha -subunit (~110 kDa) and a highly glycosylated beta -subunit (~35 kDa). For both enzymes, the structural determinants required for enzymatic function have been mapped to the alpha -subunits, whereas the beta -subunits are required to ensure the structural integrity of the protein and for delivery of the heterodimeric pump complex to the plasma membrane (for review see Ref. 1). The Na,K-ATPase is ubiquitous, whereas the gastric H,K-ATPase is primarily found in gastric parietal cells (2), though it has been detected in the kidney as well (3). The alpha -subunits of these two P-type ATPases are 62% homologous, and their hydropathy plots are virtually identical. However, the proteins exhibit major functional differences. Whereas the Na,K-ATPase exports three Na+ ions from the cytoplasm to the extracellular side in exchange for two K+ ions, the H,K-ATPase secretes two protons in exchange for two potassium ions (1).

The high degree of similarity between the Na,K-ATPase and the gastric H,K-ATPase allows their functional determinants to be studied through the generation of chimeras. By exchanging sequence domains and analyzing the functional properties of the resultant chimeric proteins it is possible to identify protein segments that are critical for the different physiological properties of the pumps. We have previously reported that the N-terminal halves of the alpha -subunits of the Na,K- and H,K-ATPases in part determine their distinct ion specificities (4). The N-terminal half of each alpha -subunit includes the first four transmembrane domains (TM1-TM4)1 as well as half of the large cytoplasmic loop connecting TM4 and TM5. To analyze this region further, a chimera was prepared in which the ectodomain between TM3 and TM4, the fourth transmembrane domain, and the N-terminal half of the large cytoplasmic loop between TM4 and TM5 (amino acids 309-506)2 of the Na,K-ATPase alpha -subunit were replaced by the complementary portions of the H,K-ATPase. The chimera was transfected into polarized LLC-PK1 pig kidney epithelial cells and was found to accumulate at the apical plasma membrane. When these cells were grown on permeable filter supports, an ouabain-sensitive acidification of the medium bathing their apical surfaces was observed.3 These data suggest that residues in TM4 and/or its flanking sequences confer the capacity to mediate proton transport. We were not able to analyze the kinetic properties of this chimera, because we could not reliably detect chimera-associated ATPase activity.

To define more precisely these amino residues that are critical for the cation selectivity, we have begun to characterize chimeras that have only portions of the Na,K-ATPase sequence between amino acids 309 and 506 replaced by their H,K-counterparts. Recently we have reported that a chimera comprising the Na,K-ATPase sequence in which the proximal half of the cytoplasmic loop (amino acids 343-506) is replaced by the corresponding H,K-ATPase sequence has an altered cation selectivity. In ATPase assays at pH 6.0 this chimera achieved 28% of its maximal activity without any added sodium in the assay solution, whereas there is no detectable sodium-independent activity for the wild type enzyme. This suggests that protons can substitute for Na+ ions in the catalytic cycle of the pump (4).

Extensive site-directed mutagenesis studies performed on the Na,K- and Ca-ATPase indicate that amino acid residues that reside in four of the predicted transmembrane domains (TM4, TM5, TM6, and TM8) make important contributions to cation binding. Each of these amphiphatic helices contains charged and polar residues whose side chains might be expected to participate in the formation of cation binding sites. Results from several labs indicate that mutations in the fourth transmembrane domain of the Ca-ATPase change this pump's apparent affinity for Ca2+ (for review see Ref. 6). Comparable results have been obtained for the Na,K-ATPase.

In the present study we dissect further the relevance to cation selectivity of selected TM4 residues together with the extracellular ectodomain (residues 309-342). The TM4s of the two pumps differ by only eight amino acid residues. We found that the replacement of only three Na,K-ATPase residues with their H,K-counterparts (L319F, N326Y, and T340S) has dramatic effects on pump function. These three mutations in TM4 together with the exchange of the ectodomains between TM3 and TM4 yield an ATPase, which at pH 6.0 achieves more than 50% of its maximal Na,K-ATPase activity in the absence of sodium. A control construct that only incorporated the ectodomain replacement but not the mutations in TM4 showed only 13% sodium-independent ATPase activity at pH 6.0. Our data suggest, therefore, that these three amino residues play an important role in determining the distinct cation selectivity properties of the Na,K- and H,K-ATPase.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Construction and Expression of Chimeras-- The chimeras presented in this paper were constructed between the rat Na,K-ATPase alpha 1-subunit (cDNA provided by E. Benz, Johns Hopkins University) and the rat gastric H,K-ATPase alpha -subunit (cDNA provided by G. Shull, University of Cincinnati). The Kunkel method of site-directed mutagenesis was used to silently introduce ApaI, AccI, and HpaI restriction sites into the two cDNAs. An ApaI site was created in the Na,K-ATPase to match the site existing in the H,K-ATPase at base pair 465 corresponding to amino acid 85. The AccI and HpaI sites corresponding to H,K-ATPase amino acids 329 and 356 were introduced into both cDNAs. Chimera H85N was generated by subcloning the small ApaI fragment of the H,K-ATPase into the larger ApaI fragment of the Na,K-ATPase. The ecto and ecto + A chimeras were constructed by ligating annealed synthetic oligonucleotides between the AccI and HpaI sites of the H85N chimera. The oligonucleotide 5'-ATACCTTCCT TCGGGCTGTC ATCTTCCTCA TTGGTATCAT CGTAGCCAAC GTGCCGGAAG GTTTGCTAGC CACCGTCACG GTATGTCTGA CGTT-3' and its complementary strand were used for the ecto chimera. The oligonucleotide 5'-ATACCTTCCT TCGGGCCGTC ATCTTCTTCA TTGGTATTAT CGTAGCCTAT GTGCCTGAGG GGCTGCTAGC TACTGTCACG GTCTGCCTGT CGTT-3' and its complementary strand were used for the ecto + A chimera. Construction of the chimeras took place in either the pBluescript or pSP72 vector (Promega Corp, Madison, WI). Once the chimeras were sequenced through their ligation points, they were subcloned into expression vectors suitable for the different expression systems.

For expression in Xenopus oocytes the cDNAs encoding the constructs were excised from pBluescript using the ClaI and XbaI restriction sites and ligated into a modified pBluesript vector using ClaI and SpeI sites. The modified pBluescript vector, enhanced for Xenopus oocyte expression, was kindly provided by William Joiner, Yale University. The polylinker of the vector is flanked by the 5'- and 3'-untranslated region sequences of Xenopus beta -globin. This modification has been shown to boost mRNA stability and expression levels in Xenopus oocytes (7). The 5'-untranslated region is inserted between the KpnI and the ApaI sites of the pBluescript-KS vector. The 3'-untranslated region plus a poly(A) sequence was ligated into the vector using the BstEII site and the BsmI site. For in vitro transcription of the chimera cDNAs, the vector was linearized with XbaI, which cuts downstream from the poly(A) sequence. An Ambion T3 mMessage-mMachine kit was used for the transcription reaction. Oocytes were obtained and treated according to standard methods (8). Xenopus oocytes were injected with 50 nl of cRNA solution containing a total of 16 ng of alpha -subunit and 12 ng of Na,K-ATPase beta 1-subunit RNA. Oocytes were maintained in ND96 medium supplemented with 5 mM pyruvate and 50 µg/ml gentamycin (Life Technologies, Inc.). They were used for experiments on day 3 or 4 postinjection.

For expression in LLC-PK1 cells, the chimeric cDNAs were subcloned behind a cytomegalovirus promoter in the mammalian expression vector pCB6 (kindly provided by M. Roth, University of Texas Southwestern), which carries resistance to the antibiotic G418 (Life Technologies, Inc.). Transfection, antibiotic selection, screening for expression, and ouabain selection were carried out as described in Ref. 4.

Electrophysiology-- Electrophysiological measurements of pump currents were performed essentially as described by Horisberger et al. (9) with the following minor modifications. Prior to measurements, oocytes were loaded with sodium by incubating them for 2 h at room temperature in a K+- and Ca2+-free medium (97 mM Na+, 0.82 mM Mg2+, 0.5 mM EGTA, 22.5 mM Cl-, 76 mM gluconate, 10 mM Hepes, pH 7.4). They were subsequently incubated for 15 min in potassium-free bath solution (97 mM Na+, 0.82 mM Mg2+, 0.42 mM Ca2+, 5 mM Ba2+, 22.5 mM Cl-, 76 mM gluconate, 2 µM ouabain, and 10 mM Hepes, pH 7.4). This solution contains barium to block nonspecific potassium currents and 2 µM ouabain to inhibit endogenous Xenopus Na,K-ATPase. Finally, oocytes were placed in the chamber of the voltage clamp setup, which initially contained the same potassium-free bath solution. Whole cell currents were measured at a holding potential of -50 mV in the following manner: after the baseline had stabilized with the oocyte in the potassium-free bath, the solution was exchanged for a potassium-containing solution, and the potassium-induced current was recorded. The potassium-free and potassium-containing solutions differed only by the replacement of a fraction of the Na+ ions with K+ ions. The total concentration of Na+ and K+ was always 97 mM. To ensure that the observed current was pump-mediated, it was suppressed by replacing the potassium-containing solution with an identical solution to which 5 mM ouabain had been added. The data were obtained using a Warner Instruments Oocyte-Clamp 725C (Warner Instruments, Hamden, CT) and analyzed with Pulse and Pulsfit software from HEKA (Darmstadt, Germany). The pump currents were plotted against the corresponding potassium concentrations and fitted to the Hill equation,
I=I<SUB><UP>max</UP></SUB>/{1+(K<SUB>1/2i</SUB>/[K<SUP>+</SUP>])<SUP>n</SUP>} (Eq. 1)
where Imax is the maximal or saturated current, K1/2i is the half activation constant for the ionic current, [K+] is the potassium concentration in the bath, and n is the Hill coefficient.

Preparation of Plasma Membranes-- The following procedure was performed entirely on ice. It has been modified from the method published by Vilsen (10). After LLC-PK1 cells were grown to confluence in 10-cm tissue culture dishes, they were washed twice with phosphate-buffered saline. They were harvested by scraping with a rubber policeman into 500 µl of a solution containing 250 mM sucrose, 20 mM Tris·HCl, and 1 mM EDTA at pH 7.5. The cells were then sonicated for 1 min using a Branson Sonifier 250 (Branson, Danbury, CT) at an amplitude of 30% on constant duty cycle. The sonicated membranes were spun in a Beckman tabletop centrifuge at 3000 × g for 10 min. The pellet was discarded, and the supernatant was combined with an equal volume of a solution of 1 M NaI, 5 mM MgCl2, 20 mM EDTA, and 160 mM Tris at pH 8.3. This membrane suspension was incubated for 10 min on ice before the membranes were pelleted by ultracentrifugation at 48,000 × g for 90 min. The supernatant was aspirated, and the pellet was resuspended and washed in a sodium-free Tris-EDTA solution (10 mM Tris, 1 mM EDTA, pH 7.4). The membranes were pelleted a second time by ultracentrifugation and resuspended in the same sodium-free Tris-EDTA solution. To homogenize the membrane suspension it was again sonicated for 30 s before the yield was determined with the Bio-Rad protein assay. The membranes were frozen at -80 °C until they were used for experiments.

ATPase Assay-- ATPase assays were carried out using a colorimetric procedure for measuring inorganic phosphate released from ATP (11, 12). Prior to the assay (except potassium-free assay, see below), the crude plasma membranes were permeabilized by incubation in 0.65 mg/ml deoxycholic acid, 2 mM EDTA, and 20 mM imidazole for 30 min at room temperature. Assays were initiated by adding 25 µl of the membrane suspension to a 475-µl assay solution containing 3 mM MgCl2, 3 mM Tris-ATP, 25 mM imidazole. For sodium titration experiments the assay solutions also contained 20 mM KCl, NaCl, and N-methyl-D-glucamine (NMDG). The combined concentration of NaCl and NMDG was maintained constant at 130 mM to ensure constant ionic strength. For pH titration experiments, the assay solutions contained 20 mM KCl and either 130 mM NMDG or 60 mM NaCl and 70 mM NMDG. For vanadate titration experiments the assay solutions contained 20 mM KCl, 60 mM NaCl, and 70 mM NMDG. The assay solutions for potassium titration experiments contained 100 mM NaCl, KCl, and NMDG, and the combined concentration of the latter two ions was constant at 30 mM.

To ensure that each assay measured similar levels of ATPase activity, different amounts of protein were added to the assay medium, depending upon the chimera being tested and the pH of the assay medium. Protein additions were adjusted so that during 2 h of incubation at 37 °C at least 4%, but no more than 10% of the total ATP (3 mM), would be hydrolyzed under Vmax conditions. Thus, typical total protein added for pH 7.5 assays was 5-8 mg/test tube for H85N and 8-12 mg for ecto and ecto+A. At pH 6.0 the total protein was increased by 50-100% for each chimera. After 2 h of incubation the reaction was stopped by adding 1 ml of ice-cold stop solution (0.5 M HCl, 3% ascorbic acid, 0.5% ammonium molybdate, and 1% SDS), which was always freshly prepared. All tubes were then transferred to an ice-cold water bath, and 1.5 ml of a solution with 2% sodium meta-arsenite, 2% sodium citrate, and 2% acetic acid was added to each tube. For color development of the phosphate assay the test tubes were incubated at 37 °C for 10 min. Free inorganic phosphate was determined by reading the optical density for each test tube at 850 nm on a Perkin-Elmer Lambda 3B spectrophotometer. In every experiment each data point was measured in triplicate, and the chimera-specific ATPase activity was determined as the signal difference from tubes containing either 10 µM (to inhibit endogenous Na,K-ATPase) or 5 mM ouabain.

Sodium orthovanadate (Sigma) was prepared as an ~10 mM stock solution at pH 9.0. Prior to the experiments an aliquot was boiled for at least three minutes, and the vanadate concentration was determined spectrophotometrically at lambda  268 nm (13).

Individual experiments were carried out in triplicates. They were averaged and normalized to the maximal enzymatic activity (Vmax), which was computed by fitting the data to a Hill function, V = Vmax/{1 + (K1/2(X+)/[X+])n}. Each individual experiment was performed at least three times. The data of the individual experiments were averaged and again fitted to the Hill function. The values shown are the means of at least three experiments, and the error bars correspond to the standard deviation between the values obtained in individual experiments. The data are presented as percentage of maximal activity (Vmax). The apparent K1/2 values were also obtained from the same data fits.

Potassium-free Na-ATPase Assays-- Membranes were first permeabilized in a solution containing 1% bovine serum albumin and 0.65 mg/ml SDS in 15 mM Tris·HCl, pH 7.4, for 10 min at room temperature, after which they were diluted 50-fold with 0.3% bovine serum albumin (14). The permeabilized membranes were then pretreated for 10 min at 37 °C with 0.5 volume of a solution comprising either 10 mM or 13.3 µM ouabain in 26.7 mM Tris·HCl, pH 7.4, 26.7 mM EGTA-Tris, 16 mM MgSO4, and 5.34 mM EDTA-Tris. The assay was initiated by adding a 0.25 volume [gamma -32P]ATP and NaCl (final concentrations, 1 µM and 2 mM, respectively) containing the indicated final concentrations of vanadate. Assays were carried out as described by Daly et al. (15), and values shown are the differences in the averages of two sets of triplicates, the one set with low (5 µM) ouabain and the other with high (5 mM) ouabain.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Chimera Design-- As discussed in the introduction, the portion of the Na,K-ATPase alpha -subunit residing between TM3 and the fluorescein isothiocyanate binding site (residues 309-506) appears to be important in determining cation selectivity. We have previously shown that a portion of this selectivity is attributable to the sequence domain bounded by amino acids 343 and 506, which constitutes roughly half of the large cytoplasmic loop connecting transmembrane segments 4 and 5 (Fig. 2A). The goal of this study is to further elucidate the role of residues 309-342 of the Na,K-ATPase in determining the cation selectivity properties of the pump. These residues comprise the ectodomain between TM3 and TM4 and all of TM4. Initially, a chimera was generated that had amino acids 309-342 exchanged for the corresponding sequence from the H,K-ATPase alpha -subunit (Fig. 2A). Although this construct assembles with the beta -subunit and is delivered to the cell surface, no enzymatic activity could be detected (data not shown). We chose, therefore, to generate new pump constructs incorporating more narrowly defined substitutions.

Extensive mutagenesis studies have demonstrated that specific residues of the Ca-ATPase, which is structurally and functionally homologous to both the Na,K- and H,K-ATPase alpha -subunits, play a role in cation binding. Fig. 1A depicts helical wheel representations of the TM4s of the Na,K- and H,K-ATPase. Residues marked with asterisks correspond to the positions of the five Ca-ATPase amino acids (Ala-305, Ala-306, Glu-309, Gly-310, and Pro-312), which have been shown to play a role in calcium translocation (6, 16). It is interesting to note that all five residues are predicted to lie on the same helical face. It would appear, therefore, that TM4 has two domains or faces, one of which is likely to be directed toward the presumed ion translocation pore, whereas the other may face the surrounding lipid domain or adjoining helices. These two putative faces are separated by a dashed line (Fig. 1A).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 1.   Helical wheel representation of the fourth transmembrane domains (TM4) of the Na,K- and gastric H,K-ATPase alpha -subunits. Of the 29 amino acids, which are thought to form TM4, only eight differ between Na,K- and H,K-ATPase. They are depicted in black bold face. A, mutational analysis of the Ca-ATPase indicates that the five positions marked with an asterisk play a role in cation translocation (6, 16). These five residues reside on the same half of the helix, suggesting that this helical face might be oriented toward the putative cation translocation pore of the P-type ATPases. In contrast, the face on the opposite side of the dashed line might confront surrounding lipid and adjoining helices. In this study we have replaced the Na,K residues above the dashed line with their H,K-counterparts. The resulting mutations are L319F, N326Y, and T340S. B, the sequences shown in this alignment were used for the helical wheel analysis shown above.

Fig. 1B shows a sequence alignment of the TM4s of the Na,K- and H,K-ATPase alpha -subunits. The TM4s of Na,K- and H,K-ATPase differ at only eight amino acid positions marked by the solid black letters. Of these eight residues, only Leu-319, Asn-326, and Thr-340 of the sodium pump are located in the domain that faces the putative ion translocation pore (Fig. 1A). We have hypothesized, therefore, that these three residues might be intimately involved in establishing the distinct cation selectivities of the Na,K- and H,K-pumps. To test this possibility, construct ecto + A (Fig. 2B) was generated, which had these three TM4 residues mutated to their H,K-counterparts (L319F, N326Y, and T340S), and includes the ectodomain between TM3 and TM4. This ectodomain replacement resulted in two amino acid replacements compared with the sodium pump sequence, W312F, and E314R (Fig. 2C). To control for a contribution of the ectodomain the construct ecto was produced, which had only the ectodomain replaced with its H,K-ATPase counterpart (Fig. 2B).


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 2.   Schematic diagram of the Na,K-ATPase and representations of the three constructs employed in this study. A, the residue numbers indicated in this map of the Na,K-ATPase correspond to the amino acids that mark segment boundaries in the chimeric constructs that are mentioned throughout the paper. In addition, the three TM4 residues that are mutated in construct ecto + A are indicated. aa, amino acid. B, the sequences depicted in white are from Na,K-ATPase, whereas the black domains and residues are from gastric H,K-ATPase. The construct H85N at the top is used as the wild type control for this study. The swap of the first 85 amino acids does not produce functional consequences but provides a useful epitope tag for a specific antibody. This tag is included in all of the constructs. Construct ecto + A is shown at the bottom. It contains the three mutations in TM4 (L319F, N326Y, and T340S), which were indicated in Fig. 1, plus the ectodomain between TM3 and TM4 from H,K-ATPase. The rationale for the construct design is explained in the beginning of the result section. Of the six amino acids comprising this ectodomain only two are different between the two pumps, resulting in alterations W312F and E314R. Construct ecto, which is depicted in the middle, serves as a control for effects introduced by the ectodomain swap. C, sequence alignment of the ectodomain between TM3 and TM4.

Finally, for both constructs the first 72 amino acids of the Na,K-ATPase were replaced with the corresponding H,K-ATPase sequence, which consists of 85 amino acids. An antibody specific to this epitope allows us to distinguish the chimeric constructs, expressed in LLC-PK1 cells or Xenopus oocytes, from endogenous Na,K-ATPase. Previous studies demonstrated that this swap does not alter the functional properties of the Na,K-ATPase (4). Thus, construct H85N, which had only the N-terminal replacement, was used as the "wild type" control throughout the study (Fig. 2).

Measurements of Potassium-induced Ouabain-sensitive Pump Currents-- A two-electrode voltage clamp of oocytes from Xenopus laevis was used to assess whether the chimeric constructs catalyze electrogenic ion fluxes. We took advantage of the species-dependent differences in ouabain sensitivity of the Na,K-ATPase to distinguish current driven by the exogenous recombinant pumps from that mediated by the endogenous sodium pumps of the oocytes. Because the alpha 1-isoform from rat (Ki ~ 10-4 M) was used for the construction of all our chimeras, we could inhibit the endogenous Na,K-ATPase (Ki ~ 10-7 M) with a low concentration of ouabain (2 µM) without affecting chimera activity. Under conditions that inhibited the background potassium currents in the oocytes, all three constructs were able to produce a potassium-activated outward current (Fig. 3, A-C). This current could be inhibited by adding 5 mM ouabain, and as expected, the ouabain block was reversible. We also used this system to determine the apparent affinities of the chimeric pumps for K+. Clamping the oocytes at a holding potential of -50 mV, we stepwise increased the potassium concentration of the bath solution and recorded the current response (Fig. 3D). The observed plateau currents were plotted versus the corresponding potassium concentration. The resulting potassium activation curves allowed computation of the apparent K1/2 values. Averaging over four to six different oocytes for each construct and fitting the data to a Hill function, we found that K1/2(K+) = 5.6 mM for ecto + A, whereas K1/2(K+) = 0.56 mM and K1/2(K+) = 1.16 mM for the controls H85N and ecto, respectively. Hill coefficients were between 1.5 and 1.7 for all three constructs. The K1/2 of 5.6 mM for ecto + A represents only a lower estimate, because the highest K+ concentration employed did not yield a saturated current. The K1/2 value for H85N corresponds well to what has been reported earlier for the wild type sodium pump under similar ionic conditions (10, 17).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3.   Potassium dependence of ouabain sensitive current measured by two-electrode voltage clamp in X. laevis oocytes. The experimental details are described under "Experimental Procedures." The current trace for a typical experiment is shown in D. The black bar represents the interval in which K+ was present in the bath. The concentrations are given in the figure. The plateau currents were plotted against the corresponding potassium concentrations, and the data were fitted to a Hill function as shown in the three other panels. For H85N (A) the half maximal activation concentration was computed to be K1/2c = 0.56 mM, for ecto (B) K1/2c = 1.16 mM, and for ecto + A (C) K1/2c = 5.6 mM. All data were normalized averages over at least four different oocytes.

ATPase Measurements-- For all of the following experiments crude plasma membranes from stably transfected LLC-PK1 cells were used. The LLC-PK1 cell line is derived from pig kidney. Pig Na,K-ATPase alpha 1 has a Ki for ouabain of approximately 10-7 M, whereas the rat-alpha 1, which was used for our constructs, is only slightly affected by this low concentration of ouabain (Ki ~ 10-4 M). Thus, at all times the assay solutions contained a low concentration of ouabain (10 µM), which is sufficient to inhibit the endogenous but not the exogenous Na,K-ATPase.

Sodium Dependence of the Ouabain-sensitive ATPase-- We assessed the Na+ dependence of the ATPase activity of our constructs. The sodium titration experiments were performed both at pH 7.5 and at pH 6. At pH 7.5 the apparent sodium affinities for all three constructs were not significantly different from what had been reported for wild type enzyme. The K1/2 for ecto + A was 8.2 mM, for H85N it was 8.3 mM, and for ecto 9.2 mM (Fig. 4). Under similar ionic conditions Vilsen (10) reported a K1/2(Na+) of 7.1 mM for the wild type enzyme.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 4.   Sodium dependence of ouabain-sensitive ATPase activity. Sodium titrations of the ATP hydrolysis activity were carried out at pH 7.5 (open circle ), and pH 6.0 (). The incubation solution contained 3 mM ATP, 3 mM Mg2+, and 20 mM K+. The endogenous Na,K-ATPase was inhibited by the addition 10 µM ouabain (for details refer to "Experimental Procedures"). The data shown are the averages of at least three independent assays, each of which was performed in triplicate. A Hill function was employed to model the data and to compute the K1/2(Na+). At pH 7.5, K1/2(Na+) for H85N (A) is found to be 8.4 mM. It is 9.2 mM for ecto (B) and 8.2 mM for ecto + A (C). At pH 6.0 the K1/2(Na+) for H85N (A) is 9.5 mM. For ecto (B) it shifts to 5.6 mM, and for ecto + A (C) a dramatic shift to 1.5 mM is observed. Furthermore, at pH 6.0 the sodium-independent ATPase activity of construct ecto + A amounts to 53% of Vmax. For ecto it is 13%, and for H85N it is only 7%.

At pH 6.0 the findings for the ecto + A construct differed strikingly from those for the controls H85N and ecto. The apparent K1/2(Na+) for ecto + A was only 1.5 mM, whereas H85N and ecto yielded K1/2(Na+) values of 9.4 and 5.6 mM, respectively. Hill coefficients were between 1.1 and 1.5. It was especially interesting to note that the ATPase activity for ecto + A in the absence of sodium was 53% of Vmax, whereas for H85N the ouabain-sensitive ATPase activity with no sodium added to the incubation solution was only 5% of maximal. For ecto the ATPase activity under the same conditions was 13% of Vmax (Fig. 4). It would appear, therefore, that at low pH ecto + A can catalyze a substantial sodium-independent ATPase activity. This observation is consistent with the possibility that protons can effectively substitute for Na+ ions in the ecto + A chimera. According to this interpretation, the apparent decrease in K1/2(Na+) for ecto + A at low pH is attributable to protons replacing Na+ ions in the catalytic cycle of the pump, resulting in the loss of the requirement for cooperative sodium binding.

pH Dependence of Ouabain-sensitive ATPase-- If, in fact, protons can substitute for Na+ ions in the catalytic cycle of ecto + A, we would expect that an increased proton concentration would facilitate its sodium-independent enzymatic activity. To test this hypothesis, we measured the pH dependence of the sodium-independent ATPase activity. The pH of the assay solution was varied stepwise by 0.4 pH units (corresponding to a 2.5-fold decrease in proton concentration). Within a range of pH 6.0 to pH 8.0 for each pH condition, assays were performed with either 0 or 60 mM Na+ in the incubation solution. We chose 60 mM for these experiments based on the results of the sodium titration experiments (Fig. 4), which demonstrated that this sodium concentration supports an enzymatic turnover rate close to Vmax. Comparison of the fraction of sodium-independent ATPase activity (the ratio of ATPase activity at 0 mM sodium to activity at 60 mM sodium) indicates that for construct ecto + A the sodium-independent ATP-hydrolysis increases with increasing proton concentration, whereas the proton concentration has no significant effect on H85N and only a small effect on ecto (Fig. 5). For ecto + A, at pH 6.0 the fraction of sodium-independent ATPase activity is again greater than 50%. These observations further support the hypothesis that the three residues that are mutated in TM4 of chimera ecto + A facilitate the substitution of protons for sodium ions in the reaction cycle of this pump.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 5.   pH dependence of sodium-independent ouabain-sensitive ATP hydrolysis. The pH dependence of the ATPase activity was determined with 60 and 0 mM Na+ in the incubation solution. The solutions also contained 3 mM ATP, 3 mM Mg2+, 20 mM K+, and 10 µM ouabain to abolish the endogenous sodium pump activity (details are given under "Experimental Procedures"). At 60 mM Na+ the pH dependence of the ATPase activity for all three constructs is almost identical to what has been observed for wild type Na,K-ATPase (data not shown). The plot represents the fraction of sodium-independent ATPase activity at different pH values. A very strong pH dependence can be seen for construct ecto + A (), while the control constructs ecto (open circle ) and H85N (triangle ) show little or no pH dependence. Assays were done in triplicate, and the data represent averages over at least three assays.

Potassium Dependence of Ouabain-sensitive ATPase-- In light of the large shift in K1/2 for the potassium activation of pump-mediated current observed in the electrophysiological experiments (Fig. 3), it was important to investigate the potassium dependence of the ATPase activity (Fig. 6). At pH 7.5 the K1/2(K+) for ecto + A was 4.65 mM, whereas for H85N and ecto K1/2(K+) values were 1.2 and 2.75 mM, respectively. The corresponding K1/2(K+) values at pH 6.0 were 2.47 mM for ecto + A and 0.73 and 1.4 mM for the H85N and ecto, respectively. Hill coefficients were in the range of 1.3 to 1.4 for all three constructs. The apparent affinity values for K+ ions obtained from the ATPase assays are in reasonably good agreement with those for K1/2 values determined from the electrophysiological potassium titrations. Once again, ecto + A manifests a substantially lower K+ affinity than the other two constructs. The differences in the absolute K1/2(K+) values obtained in these two measurements are probably attributable to the different conditions under which they are performed. The ionic conditions are identical at the two sides of the permeabilized membranes used for ATPase assays, whereas it is impossible to control the intracellular milieu of the intact cells (oocytes) employed in the electrophysiological determinations.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 6.   Potassium dependence of ouabain-sensitive ATPase activity. Potassium-dependent ouabain-sensitive ATPase activity was measured at pH 7.5 (open circle ) and pH 6.0 (). The incubation solution contained 3 mM ATP, 3 mM Mg2+, and 100 mM Na+. To inhibit the endogenous sodium pump all solutions contained 10 µM ouabain (for details refer to "Experimental Procedures"). Each assay was performed in triplicate, and for each condition the data shown are the averages of at least three assays. The data were fitted to a Hill function. At pH 7.5 the following K1/2(K+) were computed: for H85N (A) 1.2 mM, for ecto (B) 2.8 mM, and for ecto + A (C) 4.6 mM. At pH 6.0 K1/2(K+) was determined to be 0.74 mM for H85N (A), 1.4 mM for ecto (B), and 2.5 mM for ecto + A (C).

Vanadate (VO43-) Inhibition of Ouabain-sensitive ATPase-- It is possible that the observed shifts in apparent affinity for potassium are due to a change in the steady-state E1/E2 conformational equilibrium in favor of E1. To gain insight into this issue, we examined the inhibition of enzymatic activity by inorganic orthovanadate. Like inorganic phosphate, orthovanadate acts as a transition state analog, preferentially binding to the E2 conformation of P-type ATPases to form a relatively stable intermediate (18-20). Thus, if the ecto + A construct preferentially accumulates in the E1 conformations, we would expect to observe a larger IC50 value for vanadate inhibition.

Measurements of the vanadate sensitivities of the two control chimeras, H85N and ecto, and the ecto + A mutant were carried out under Vmax conditions at pH 7.5 and 6.0. IC50 values for the vanadate-sensitive component of ouabain-sensitive ATPase activities were 15, 42, and 151 µM for H85N, ecto, and ecto + A, respectively. At pH 6.0, IC50 values were 26, 61, and 203 µM for H85N, ecto, and ecto + A, respectively (data not shown). It is interesting that the relationship between the IC50 (VO43+) values obtained for the three constructs is similar to that observed for the apparent K+ affinities. This finding is consistent with the interpretation that the conformational equilibrium of the ecto + A construct is shifted to favor of E1 forms. Finally, it should also be noted that the IC50 of 15 µM for H85N corresponds well to observations of the wild type Na,K-ATPase conducted by Friedrich et al. (21) and Smith et al. (22).

To rule out the possibility that the changes in vanadate sensitivity are secondary to changes in K+ affinity, vanadate titrations were also carried out in the absence of K+. These titrations were carried out at a low (micromolar) ATP concentration that, in absence of K+, is sufficient to saturate the ATP binding site and thus enable the accurate determination of low activity Na-ATPase activity. As shown in Fig. 7, the ~10-fold difference in sensitivity between ecto and ecto + A persists in the absence of K+. The IC50 for ecto was close to that for H85N (not shown).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 7.   Vanadate inhibition titration of ouabain-sensitive ATPase activity in the absence of potassium. The assay was carried out in the absence of potassium and in the presence of 1 µM [gamma -32P]ATP and 2 mM NaCl. The solution also contained 5 µM ouabain to suppress contributions from the endogenous sodium pump (for details see "Experimental Procedures"). The data illustrate that the large shift in vanadate IC50 for ecto + A (open circle ) compared with ecto (). Vanadate inhibition of construct H85N was virtually identical to the inhibition observed for ecto (not shown). The data shown are a representative single experiment carried out in triplicate.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The data presented here demonstrate that residues of the TM4 segments of the Na,K-ATPase and H,K-ATPase alpha -subunits are important for determining the distinct cation selectivities of these enzymes. A helical wheel analysis led us to propose that three TM4 residues might be especially relevant to cation selectivity. A construct ecto + A was generated in which the corresponding residues of H,K-ATPase alpha -subunit TM4 were substituted into the sequence of Na,K-ATPase alpha -subunit (L319F, N326Y, and T340S). When the activity of ecto + A was assayed at pH 6.0, it exhibited sodium-independent ATP hydrolysis, which was more than 50% of its Vmax activity. This activity was not observed for the wild type-like H85N construct, and the ecto control construct had only slightly elevated sodium-independent ATPase activity. The sodium-independent ATPase activity was strongly pH-dependent, and at pH 7.5 it was not detectable. The likeliest explanation for the sodium-independent ATPase activity of ecto + A is that protons can substitute for sodium ions in this catalytic cycle of the construct. This conclusion is strongly supported by the pH dependence of the sodium-independent ATP hydrolysis, which is shown in Fig. 5. An increase in pH from pH 6 to pH 6.4 (corresponding to a 2.5-fold decrease in proton concentration) reduced the sodium-independent ATPase almost 2-fold.

In addition to the sodium-independent ATPase activity observed for ecto + A, we found that the K1/2(Na+) for this construct decreased from 8.2 mM at pH 7.5 to 1.5 mM at pH 6.0 (see Table I). This is kinetically consistent with a loss, at low pH, of the normal requirement of Na,K-ATPase for cooperative binding of three sodium ions to drive ATP hydrolysis and pump turnover. Replacement of one or two Na+ ions by protons in the transport cycle would explain the observed behavior. If at pH 6.0, for example, two internal cation binding sites were occupied with protons or hydronium ions, the sodium stimulation as shown in Fig. 4 could reflect the binding of only one sodium ion to the third, highly specific sodium binding site. Indeed, the K1/2(Na+) of 1.5 mM is in reasonably good agreement with K1/2 values reported by Schneeberger and Apell (23) for the binding of the third sodium ion.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Summary of all K1/2 and IC50 values determined in this study
All values are given in mM, except for vandate IC50, which is given in µM. All ATPase activity experiments were performed in the presence of 3 mM ATP, 3 mM Mg2+, and 10 µM ouabain to inhibit endogenous Na,K-ATPase. Sodium titrations were performed in the presence of 20 mM K+, potassium titrations in the presence of 100 mM Na+, vanadate titrations in the presence of 20 mM K+ and 100 mM Na+. Constant ionic strength was ensured by adding appropriate concentrations of NMDG. For complete details see "Experimental Procedures."

In considering the structural basis for the change in the sodium versus proton selectivity observed with the ecto + A construct, it is tempting to focus on the exchanges L319F and N326Y, which introduce two bulkier aromatic residues into the presumed cation translocation pore. The larger side chains of these residues might be expected to present a greater physical barrier for the binding and transport of the larger sodium ion compared with a proton. The validity of this argument is, of course, predicated on the extent to which the ions are hydrated.

In addition to the altered selectivity for sodium versus protons, a large (5-10-fold) decrease in apparent affinity for potassium was observed with construct ecto + A in ATPase assays and in current measurements (Table I). This observation led us to propose that in addition to altering the cation selectivity, the substitution of the TM4 residues also leads to a shift in the E1/E2 conformational equilibrium. Further experimental evidence supports this interpretation. Thus, the IC50 shifts that were observed for vanadate inhibition of the ecto + A construct resemble the shifts observed for potassium K1/2. It should be noted, however, that although these findings are consistent with a shift in conformational equilibrium, they do not constitute rigorous proof of such an alteration.

We cannot, for example, exclude the possibility that the intrinsic affinities of the K+ and vanadate binding sites were altered. Thus, it is possible that the mutation E314R in the ectodomain between TM3 and TM4 reduces the intrinsic K+ affinity because the replacement of a negatively charged glutamate with a positively charged arginine residue might cause a stronger electrostatic repulsion near the access to the extracellular K+ binding sites. This could explain the small K1/2(K+) shift observed for the ecto construct, but the vanadate IC50 shift and the large K1/2(K+) shift found for the ecto + A construct are unlikely to be due to a change in the intrinsic affinities for K+ and vanadate. The shift in vanadate IC50 persisted in the absence of potassium (Fig. 7), so we can rule out the possibility that it is only secondary to a change in the intrinsic potassium affinity (24). The possibility that the vanadate binding site itself has been altered also seems very unlikely, because none of the mutated residues are part of the presumed vanadate binding site or are even a close neighbor in the amino acid sequence. The proposed vanadate binding pocket is very highly conserved for all P-type ATPases and is thought to correspond to the region between amino acids 369 to 378 of the Na,K-ATPase (25, 26).

Additional support for a change in the E1/E2 conformational equilibrium comes from the observation that the ouabain sensitivity of the ecto + A construct is reduced compared with that of H85N. In the electrophysiological experiments 5 mM ouabain inhibited the current produced by H85N virtually completely, whereas for ecto + A a current corresponding to 15-20% of the total potassium-induced current remained in the presence of this drug. None of the residues altered in our study are thought to play a role in ouabain binding. Ouabain predominantly binds to an E2 conformation of the pump (27). The decreased efficacy of ouabain inhibition might, therefore, reflect a shift toward E1 conformations with a concomitant decrease in apparent ouabain affinity. Unfortunately, technical difficulties associated with the limited solubility of ouabain have precluded a detailed analysis of the ouabain effects. Taken together, the behavior of ecto + A toward K+, VO43+, and ouabain indicate shifts toward lower apparent affinities for three different pump ligands, all of which bind to the enzyme in the E2 conformation. These observations thus constitute strong evidence in favor of a shift in conformational equilibrium.

In a previous mutagenesis study designed to identify residues that might serve as cation ligands, the asparagine at position 326 of the Na,K-ATPase was replaced with a leucine residue (28). As a result of this mutation, the affinity for sodium decreased more than 3-fold to 24 mM, whereas the affinity for potassium did not seem to change significantly. Further experiments demonstrated that the decreased sodium affinity was not attributable to a shift in conformational equilibria. In addition to Asn-326, the residues Glu-329, Glu-781, and Thr-809 have been classified as potential sodium ligands at the high affinity cytoplasmic sites in the E1 form of the sodium pump (28). Except for Asn-326, these residues are highly conserved among P-type ATPases, and they are identical between the Na,K- and gastric H,K-ATPase (1, 29). This would suggest that at least some of the residues involved in cation binding are shared among different pumps and do not play a role in determining cation specificity. It further indicates that Asn-326 may play a critical role in distinguishing between Na+ ions and protons.

In a recent study of gastric H,K-ATPase and Na,K-ATPase chimeras (4), it was shown that the N-terminal half of the cytoplasmic loop between TM4 and TM5 (chimera H85N/H356-519N), and to a greater extent, the replacement of the entire N-terminal half of the Na,K-ATPase with the homologous gastric H,K-ATPase domain (chimera H519N) confer marked increases in selectivity for protons relative to Na+ ions, even at pH 7.4, when compared with the H85N control. The data presented here demonstrate that residues in TM4 contribute to the dramatic shift observed with H519N. It seems likely that specificity is determined through a concerted interaction between the identified residues in TM4 and sequences within the loop between TM4 and TM5. Construction of further chimeras will be required to test this proposition directly.

The results of the present study indicate that transmembrane residues can also influence conformational equilibria. Similar conclusions can be drawn from the previous Na,K-/H,K-ATPase chimera studies. Thus, the H519N but not the H85N/H356-519N displayed reduced vanadate sensitivity (4). Similarly, Vilsen (5) has shown that the mutation of Leu-332 to alanine in TM4 of the Na,K-ATPase resulted in a conformational equilibrium shift toward E1. Perhaps not surprisingly, therefore, it appears that residues in the transmembrane domains contribute to the determination of conformational equilibria as well as participating in the formation of the ion binding and conduction pathway. Conversely, analysis of the H85N/H356-519N chimera demonstrates that changes in cation affinities can be produced through mutations or substitutions outside of predicted transmembrane domains (4). The small but significant sodium-independent ATPase activity observed with ecto at low pH is also consistent with the conclusion that sequences flanking membrane domains can influence cation selectivity. The mechanism through which these separate domains of the pump molecules interact to modulate specificity and conformation remain to be established.

In conclusion, this study elucidates three specific residues of TM4 that are important for the distinct cation selectivity properties of Na,K- and H,K-ATPases. These residues also impact upon transitions among the conformational states of these enzymes. Together with our recent work (4) it becomes evident that cation selectivity of P-type ATPases is determined not only by transmembrane domains but by an interplay of transmembrane domains and their flanking regions. These findings underscore the complex and cooperative nature of cation translocation by P-type ATPases.

    ACKNOWLEDGEMENTS

We are grateful to Vanathy Rajendran and Ania Wilczynska for excellent technical support. We are also indebted to Biff Forbush, Alexander Grishin, Joe Hoffman, and Clifford Slayman for valuable discussions and advice. Special thanks to Tiffany Runyan Garrison for reading and critiquing the manuscript.

    FOOTNOTES

* This work was supported by Grants GM42136 and DR17433 from the National Institutes of Health and Grant MT-3976 from the Medical Research Council.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Dept. of Cellular and Molecular Physiology, Yale School of Medicine, 333 Cedar St., New Haven, CT 06520. Tel.: (203) 785-6835; Fax: (203) 785-4951; E-mail: Martin.Mense@yale.edu.

2 In previous publications on Na,K-/H,K-ATPase chimeras, we have used a numbering system referring to the positions of gastric H,K-ATPase residues. To facilitate the comparison of the present results to other mutagenesis studies of the Na,K-ATPase, we have employed a numbering system based on the Na,K-ATPase sequence in this manuscript. It should be noted that the Na,K-ATPase amino acid residues 343-506 correspond to amino acids 356-519 of the H,K-ATPase in the chimera H85N/H356-519N (4).

3 L. A. Dunbar, P. Aronson, and M. J. Caplan, submitted for publication.

    ABBREVIATIONS

The abbreviations used are: TM, transmembrane domain; NMDG, N-methyl-D-glucamine.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Moller, J. V., Juul, B., and le Maire, M. (1996) Biochim. Biophys. Acta 1286, 1-51[Medline] [Order article via Infotrieve]
2. Courtois-Coutry, N., Roush, D., Rajendran, V., McCarthy, J. B., Geibel, J., Kashgarian, M., and Caplan, M. J. (1997) Cell 90, 501-510[CrossRef][Medline] [Order article via Infotrieve]
3. Doucet, A. (1997) Exp. Nephrol. 5, 271-276[Medline] [Order article via Infotrieve]
4. Blostein, R., Dunbar, L. A., Mense, M., Scanzano, R., Wilczynska, A., and Caplan, M. J. (1999) J. Biol. Chem. 274, 18374-18381[Abstract/Free Full Text]
5. Vilsen, B. (1997) Biochemistry 36, 13312-13324[CrossRef][Medline] [Order article via Infotrieve]
6. Andersen, J. P., and Vilsen, B. (1995) FEBS Lett. 359, 101-106[CrossRef][Medline] [Order article via Infotrieve]
7. Krieg, P. A., and Melton, D. A. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 2331-2335[Abstract/Free Full Text]
8. Fyfe, G. K., and Canessa, C. M. (1998) J. Gen. Physiol. 112, 423-432[Abstract/Free Full Text]
9. Horisberger, J. D., Jaunin, P., Good, P. J., Rossier, B. C., and Geering, K. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 8397-8400[Abstract/Free Full Text]
10. Vilsen, B. (1992) FEBS Lett. 314, 301-307[CrossRef][Medline] [Order article via Infotrieve]
11. Jorgensen, P. L., and Petersen, J. (1982) Biochim. Biophys. Acta 705, 38-47[CrossRef][Medline] [Order article via Infotrieve]
12. Ottolenghi, P. (1975) Biochem. J. 151, 61-66[Medline] [Order article via Infotrieve]
13. Gordon, J. A. (1991) Methods Enzymol. 201, 477-482[Medline] [Order article via Infotrieve]
14. Forbush, B. D. (1983) Anal. Biochem. 128, 159-163[CrossRef][Medline] [Order article via Infotrieve]
15. Daly, S. E., Lane, L. K., and Blostein, R. (1994) J. Biol. Chem. 269, 23944-23948[Abstract/Free Full Text]
16. MacLennan, D. H., Toyofuku, T., and Lytton, J. (1992) Ann. N. Y. Acad. Sci. 671, 1-10
17. Kuntzweiler, T. A., Wallick, E. T., Johnson, C. L., and Lingrel, J. B (1995) J. Biol. Chem. 270, 2993-3000[Abstract/Free Full Text]
18. Harris, S. L., Perlin, D. S., Seto-Young, D., and Haber, J. E. (1991) J. Biol. Chem. 266, 24439-24445[Abstract/Free Full Text]
19. Boxenbaum, N., Daly, S. E., Javaid, Z. Z., Lane, L. K., and Blostein, R. (1998) J. Biol. Chem. 273, 23086-23092[Abstract/Free Full Text]
20. Ambesi, A., Pan, R. L., and Slayman, C. W. (1996) J. Biol. Chem. 271, 22999-23005[Abstract/Free Full Text]
21. Friedrich, T., Bamberg, E., and Nagel, G. (1996) Biophys. J. 71, 2486-2500[Abstract/Free Full Text]
22. Smith, R. L., Zinn, K., and Cantley, L. C. (1980) J. Biol. Chem. 255, 9852-9859[Abstract/Free Full Text]
23. Schneeberger, A., and Apell, H. J. (1999) J. Membr. Biol. 168, 221-228[CrossRef][Medline] [Order article via Infotrieve]
24. Sachs, J. R. (1987) J. Gen. Physiol. 90, 291-320[Abstract/Free Full Text]
25. Rao, R., and Slayman, C. W. (1993) J. Biol. Chem. 268, 6708-6713[Abstract/Free Full Text]
26. Serrano, R., and Portillo, F. (1990) Biochim. Biophys. Acta 1018, 195-199[Medline] [Order article via Infotrieve]
27. Anner, B. M., Moosmayer, M., and Imesch, E. (1994) Mol. Membr. Biol. 11, 237-245[Medline] [Order article via Infotrieve]
28. Vilsen, B. (1995) FEBS Lett. 363, 179-183[CrossRef][Medline] [Order article via Infotrieve]
29. Grishin, A. V., Sverdlov, V. E., Kostina, M. B., and Modyanov, N. N. (1994) FEBS Lett. 349, 144-150[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page